Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Director/PDMR Shareholding

3 Feb 2010 18:00

RNS Number : 6546G
PZ CUSSONS PLC
03 February 2010
 



PZ Cussons Plc (the "Company")

Announcement regarding dealing in shares

This notification is made in accordance with DR 3.1.4R(1)(a).

On 3 February 2010 Mr A Kanellis exercised options granted to him under the Company's Executive Share Option Scheme ("the ESOS") over 313,799 ordinary shares of 1p in the Company at the following exercise prices:

214,010 shares at £0.747 per share

99,789 shares at £1.104 per share

He subsequently sold 179,558 ordinary shares to the Paterson Zochonis Employee Trust ("the Trust") on 3 February for a consideration of £2.5480 per share. Mr Kanellis is Chief Executive of the Company and the Company was informed by Mr Kanellis of this dealing on 3 February. After this sale, Mr Kanellis holds 262,239 ordinary shares in the Company (comprising 0.06% of the total shares in issue).

 

On 3 February 2010 Mr C Davis exercised options granted to him under the Company's Executive Share Option Scheme over 242,040 ordinary shares of 1p in the Company at the following exercise prices:

76,900 shares at £0.747 per share

31,170 shares at £1.104 per share

 

62,900 shares at £1.298 per share

 

71,070 shares at £1.407 per share

 

He subsequently sold 242,040 ordinary shares to the Trust on 3 February for a consideration of £2.5480 per share. Mr Davis is Commercial Director of the Company and the Company was informed by Mr Davis of this dealing on 3 February. After this sale, Mr Davis holds 170,761 ordinary shares in the Company (comprising 0.04% of the total shares in issue).

The Trust is a discretionary trust under which the class of beneficiaries who may benefit comprises all bona fide employees and former employees of the Company and its subsidiaries including members of such employees' and former employees' immediate families. Accordingly, the Executive Directors and PDMRs of the Company are included in the class of beneficiaries and are deemed to have an interest in all of such shares. The Trust's holding in the ordinary shares of 1p in the Company after the dealings listed above is 1,122,496 shares (0.26%).

 

On 1 February 2010 Mr Chris How, who has been designated by the Board of the Directors of the Company as a person discharging managerial responsibility, sold 15,000 ordinary shares for a consideration of £2.45 per share. After this sale, Mr How holds 39,509 ordinary shares in the Company (comprising less than 0.01% of the total shares in issue). The Company was informed by Mr How of this dealing in shares on 1 February.

 

No new shares have been issued in respect of any of the dealings above. The current issued share capital of the company is 428,724,960 ordinary shares of 1p each.

Name of contact and telephone number for queries:

Sam Plant, Company Secretary, PZ Cussons Plc, (T) (00) 44 (0)161 491 8000

Date: 3 February 2010

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSTJMRTMBAMBRM
Date   Source Headline
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.